Atlas Trials

The Individualized M(X) Drug-resistant TB Treatment Strategy Study

Clinical trial NCT03237182 · TERMINATED

Trial details

NCT number
NCT03237182
Sponsor
Centre for the AIDS Programme of Research in South Africa
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Tuberculosis, Multidrug-Resistant
Start date
2017-06-14
Primary completion
2022-12-19
Enrollment
205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.